p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells

Código QR

p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells

Anna C Cunningham-Edmondson1,2, Steven K Hanks11Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA; 2Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta, GA, USAAbstract: Elevated Src tyrosine kinase activity is comm...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Anna C Cunningham-Edmondson, Steven K Hanks
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/5bcf7b4d79a54bf8ac44e71757d8a5bf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion.
por: Maria Silvia Giretti, et al.
Publicado: (2008)

Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion
por: Marianna Sciortino, et al.
Publicado: (2017)

Author Correction: The miR-24-3p/p130Cas: a novel axis regulating the migration and invasion of cancer cells
por: Hoin Kang, et al.
Publicado: (2021)

Survival rates of advanced estrogen-receptor positive breast cancer. Analysis of 211 cases
por: Sánchez,César, et al.
Publicado: (2020)

The actin cytoskeletal architecture of estrogen receptor positive breast cancer cells suppresses invasion
por: Marco Padilla-Rodriguez, et al.
Publicado: (2018)

Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines
por: Rangel N, et al.
Publicado: (2017)

MicroRNA- 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1 [corrected].
por: Yanyang Zhao, et al.
Publicado: (2014)

Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer
por: Della Makower, et al.
Publicado: (2021)

Estradiol analogs attenuate autophagy, cell migration and invasion by direct and selective inhibition of TRPML1, independent of estrogen receptors
por: Philipp Rühl, et al.
Publicado: (2021)

Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer
por: Kanako Hagio, et al.
Publicado: (2021)

Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis
por: Lucas Porras, et al.
Publicado: (2021)

Acta No. 130
por: Banco Central de Chile
Publicado: (2019)

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy
por: Maria Vittoria Dieci, et al.
Publicado: (2021)

Protein expression profile and microRNA expression signature in estrogen receptor-positive and -negative breast cancers: report of two cases
por: Tsunoda Y, et al.
Publicado: (2018)

The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells
por: Yainyrette Rivera-Rivera, et al.
Publicado: (2021)

Resolución 130(VII): Energía nuclear = Resolution 130(VII): Nuclear energy = Résolution 130(VII): Energie nucléaire
Publicado: (2014)

Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.
por: Sushmita Rath, et al.
Publicado: (2021)

CEPAL Review no. 130
Publicado: (2020)

Revista CEPAL no. 130
Publicado: (2020)

Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
por: Giada Zurlo, et al.
Publicado: (2019)

Estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer of Indian women
por: Patil AV, et al.
Publicado: (2011)

Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.
por: John J Kim, et al.
Publicado: (2021)

Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
por: Erin R. Scheidemann, et al.
Publicado: (2021)

Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers
por: Christopher A. Miller, et al.
Publicado: (2016)

The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia
por: Tatiana N. Sokolova, et al.
Publicado: (2021)

RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers
por: Kyoungwha Pang, et al.
Publicado: (2019)

p130Cas Is Correlated with EREG Expression and a Prognostic Factor Depending on Colorectal Cancer Stage and Localization Reducing FOLFIRI Efficacy
por: Jörg Kumbrink, et al.
Publicado: (2021)

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
por: Tamar Zahavi, et al.
Publicado: (2021)

Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells
por: Keenen MM, et al.
Publicado: (2016)

Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients
por: Wen S, et al.
Publicado: (2020)

Systematic integrated analyses of methylomic and transcriptomic impacts of early combined botanicals on estrogen receptor-negative mammary cancer
por: Itika Arora, et al.
Publicado: (2021)

Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells
por: Cook MT, et al.
Publicado: (2016)

Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race.
por: Yu Ren, et al.
Publicado: (2014)

The effects of black cohosh on the regulation of estrogen receptor (ERα) and progesterone receptor (PR) in breast cancer cells
por: Szmyd M, et al.
Publicado: (2018)

Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers
por: Al-saraireh YM, et al.
Publicado: (2021)

Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival
por: Masanori Oshi, et al.
Publicado: (2021)

Estrogens induce expression of membrane-associated estrogen receptor α isoforms in lactotropes.
por: Sandra Zárate, et al.
Publicado: (2012)

HIG1 domain family member 1A disrupts proliferation, migration and invasion of colon adenocarcinoma cells
por: Zhenyu Xu, et al.
Publicado: (2021)

Tudor Domain Containing Protein 3 Promotes Tumorigenesis and Invasive Capacity of Breast Cancer Cells
por: Alan Morettin, et al.
Publicado: (2017)

Multidomain architecture of estrogen receptor reveals interfacial cross-talk between its DNA-binding and ligand-binding domains
por: Wei Huang, et al.
Publicado: (2018)